Utility of Patient-Reported Outcome Instruments in Heart Failure

JACC: Heart Failure

Volumn 4, Issue 3, 2016, Pages 165-175

  Kelkar, Anita A ^a   Spertus, John ^b   Pang, Peter ^c   Pierson, Renee F ^d   Cody, Robert J ^d   Pina, Ileana L ^e   Hernandez, Adrian ^f   Butler, Javed ^g  

^a EMORY UNIVERSITY   (United States)

^b SAINT LUKE S MID AMERICA HEART INSTITUTE   (United States)

^c INDIANA UNIVERSITY   (United States)

^d JOHNSON AND JOHNSON   (United States)

^e MONTEFIORE MEDICAL CENTER   (United States)

^f DUKE UNIVERSITY   (United States)

^g STONY BROOK UNIVERSITY   (United States)

Author keywords

Heart failure; Patient reported outcomes

Indexed keywords

CLINICAL PRACTICE; CLINICAL TRIAL (TOPIC); HEART FAILURE; HISTORY; HUMAN; KANSAS CITY CARDIOMYOPATHY QUESTIONNAIRE; MEDICAL CARE; MINNESOTA LIVING WITH HEART FAILURE QUESTIONNAIRE; OUTCOME ASSESSMENT; PATIENT EDUCATION; PATIENT REPORTED OUTCOME; PRIORITY JOURNAL; PSYCHOMETRY; QUESTIONNAIRE; REVIEW; SYMPTOM; PATIENT-REPORTED OUTCOME;

CLINICAL TRIALS AS TOPIC; HEART FAILURE; HUMANS; PATIENT REPORTED OUTCOME MEASURES; PSYCHOMETRICS; SURVEYS AND QUESTIONNAIRES;

EID: 84959235004     PISSN: 22131779     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchf.2015.10.015     Document Type: Review

References (59)

1. Crossing the Quality Chasm: A New Health System for the Twenty-First Century 2001, Institute of Medicine, National Academy Press, Washington, DC.
2. Arnold S.V., Spertus J.A., Lei Y., et al. How to define a poor outcome after transcatheter aortic valve replacement: conceptual framework and empirical observations from the placement of aortic transcatheter valve (PARTNER) trial. Circ Cardiovasc Qual Outcomes 2013, 6:591-597.
3. Spertus J., Peterson E., Conard M.W., et al. Monitoring clinical changes in patients with heart failure: a comparison of methods. Am Heart J 2005, 150:707-715. for the Cardiovascular Outcomes Research Consortium.
4. Mackintosh A.G., Fitzpatrick R. A Structured Review of Patient-Reported Outcome Measures (PROMs) for Heart Failure 2009, University of Oxford, Oxford, UK.
5. Garin O., Herdman M., Vilagut G., et al. Assessing health-related quality of life in patients with heart failure: a systematic, standardized comparison of available measures. Heart Fail Rev 2014, 19:359-367.
6. 2015 National Impact Assessment of the Centers for Medicare and Medicaid Services (CMS) Quality Measures Report 2015, Centers for Medicare and Medicaid Services, CMS, Baltimore, MD.
7. Sepehrvand N., Ezekowitz J.A. How to do more with less. Circ Cardiovasc Qual Outcomes 2015 Aug 25, [E-pub ahead of print].
8. Higgins J.P.T., Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011) 2011, The Cochrane Collaboration, London, UK.
9. Raphael C., Briscoe C., Davies J., et al. Limitations of the New York Heart Association functional classification system and self-reported walking distances in chronic heart failure. Heart 2007, 93:476-482.
10. Goldman L., Hashimoto B., Cook E.F., Loscalzo A. Comparative reproducibility and validity of systems for assessing cardiovascular functional class: advantages of a new specific activity scale. Circulation 1981, 64:1227-1234.
11. Calkins D.R., Rubenstein L.V., Cleary P.D., et al. Failure of physicians to recognize functional disability in ambulatory patients. Ann Intern Med 1991, 114:451-454.
12. Rector T.S., Cohn J.N. Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Am Heart J 1992, 124:1017-1025. for the Pimobendan Multicenter Research Group.
13. Spertus J.A., Jones P.G. Development and validation of a short version of the Kansas City Cardiomyopathy Questionnaire. Circ Cardiovasc Qual Outcomes 2015 Aug 25, [E-pub ahead of print].
14. Spertus J. Barriers to the use of patient-reported outcomes in clinical care. Circ Cardiovasc Qual Outcomes 2014, 7:2-4.
15. Anker S.D., Agewall S., Borggrefe M., et al. The importance of patient-reported outcomes: a call for their comprehensive integration in cardiovascular clinical trials. Eur Heart J 2014, 35:2001-2009.
16. Feinstein A.R. An additional basic science for clinical medicine: IV. The development of clinimetrics. Ann Intern Med 1983, 99:843-848.
17. Guidance for Industry Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims 2009, U.S. Food and Drug Administration, U.S. Department of Health and Human Services, Food and Drug Administration, Washington, D.C.
18. McMurray J.J., Packer M., Desai A.S., et al. Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med 2014, 371:993-1004. for the PARADIGM-HF Investigators and Committees.
19. Rahimi K., Malhotra A., Banning A.P., Jenkinson C. Outcome selection and role of patient reported outcomes in contemporary cardiovascular trials: systematic review. BMJ 2010, 341:c5707.
20. Arnold S.V., Spertus J.A., Lei Y., et al. Use of the Kansas City Cardiomyopathy Questionnaire for monitoring health status in patients with aortic stenosis. Circ Heart Fail 2013, 6:61-67.
21. Joseph S.M., Novak E., Arnold S.V., et al. Comparable performance of the Kansas City Cardiomyopathy Questionnaire in patients with heart failure with preserved and reduced ejection fraction. Circ Heart Fail 2013, 6:1139-1146.
22. Green C.P., Porter C.B., Bresnahan D.R., Spertus J.A. Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure. J Am Coll Cardiol 2000, 35:1245-1255.
23. Spertus J.A., Jones P.G. Development and validation of a short version of the Kansas City Cardiomyopathy Questionnaire. Circ Cardiovasc Qual Outcomes 2015 Aug 25, [Epub ahead of print].
24. Kosiborod M., Soto G.E., Jones P.G., et al. Identifying heart failure patients at high risk for near-term cardiovascular events with serial health status assessments. Circulation 2007, 115:1975-1981.
25. Riegel B., Moser D.K., Glaser D., et al. The Minnesota Living With Heart Failure Questionnaire: sensitivity to differences and responsiveness to intervention intensity in a clinical population. Nurs Res 2002, 51:209-218.
26. Heo S., Lennie T.A., Okoli C., Moser D.K. Quality of life in patients with heart failure: ask the patients. Heart Lung 2009, 38:100-108.
27. Jiang W., Alexander J., Christopher E., et al. Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. Arch Intern Med 2001, 161:1849-1856.
28. Faller H., Steinbuchel T., Störk S., Schowalter M., Ertl G., Angermann C.E. Impact of depression on quality of life assessment in heart failure. Int J Cardiol 2010, 142:133-137.
29. Juenger J., Schellberg D., Kraemer S., et al. Health related quality of life in patients with congestive heart failure: comparison with other chronic diseases and relation to functional variables. Heart 2002, 87:235-241.
30. Moher D., Liberati A., Tetzlaff J., et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009, 6:e1000097. for the PRISMA Group. 10.1371/journal.pmed1000097.
31. Guyatt G.H., Nogradi S., Halcrow S., Singer J., Sullivan M.J., Fallen E.L. Development and testing of a new measure of health status for clinical trials in heart failure. J Gen Intern Med 1989, 4:101-107.
32. Bennett S.J., Perkins S.M., Lane K.A., Deer M., Brater D.C., Murray M.D. Social support and health-related quality of life in chronic heart failure patients. Qual Life Res 2001, 10:671-682.
33. Mansfield D.R., Gollogly N.C., Kaye D.M., Richardson M., Bergin P., Naughton M.T. Controlled trial of continuous positive airway pressure in obstructive sleep apnea and heart failure. Am J Respir Crit Care Med 2004, 169:361-366.
34. Guyatt G.H., Sullivan M.J., Fallen E.L., et al. A controlled trial of digoxin in congestive heart failure. Am J Cardiol 1988, 61:371-375.
35. Spertus J.A., Jones P.G., Kim J., Globe D. Validity, reliability, and responsiveness of the Kansas City Cardiomyopathy Questionnaire in anemic heart failure patients. Qual Life Res 2008, 17:291-298.
36. Kosiborod M., Krumholz H.M., Jones P.G., Pitt B., Spertus J.A. The relationship between anemia, change in hematocrit over time and change in health status in patients with heart failure after myocardial infarction. J Card Fail 2008, 14:27-34.
37. Conard M.W., Heidenreich P., Rumsfeld J.S., et al. Patient-reported economic burden and the health status of heart failure patients. J Card Fail 2006, 12:369-374. for the Cardiovascular Outcomes Research Consortium.
38. Heidenreich P.A., Spertus J.A., Jones P.G., et al. Health status identifies heart failure outpatients at risk for hospitalization or death. J Am Coll Cardiol 2006, 47:752-756. for the Cardiovascular Outcomes Research Consortium.
39. Heo S., Doering L.V., Widener J., Moser D.K. Predictors and effect of physical symptom status on health-related quality of life in patients with heart failure. Am J Crit Care 2008, 17:124-132.
40. Hou N., Chui M.A., Eckert G.J., Oldridge N.B., Murray M.D., Bennett S.J. Relationship of age and sex to health-related quality of life in patients with heart failure. Am J Crit Care 2004, 13:153-161.
41. Bennett S.J., Oldridge N.B., Eckert G.J., et al. Comparison of quality of life measures in heart failure. Nurs Res 2003, 52:207-216.
42. Aranda J.M., Conti J.B., Johnson J.W., Petersen-Stejskal S., Curtis A.B. Cardiac resynchronization therapy in patients with heart failure and conduction abnormalities other than left bundle-branch block: analysis of the Multicenter InSync Randomized Clinical Evaluation (MIRACLE). Clin Cardiol 2004, 27:678-682.
43. Carels R.A. The association between disease severity, functional status, depression and daily quality of life in congestive heart failure patients. Qual Life Res 2004, 13:63-72.
44. Rector T.S., Tschumperlin L.K., Kubo S.H., et al. Use of the Living With Heart Failure questionnaire to ascertain patients' perspectives on improvement in quality of life versus risk of drug-induced death. J Card Fail 1995, 1:201-206.
45. Kato N., Kinugawa K., Seki S., et al. Quality of life as an independent predictor for cardiac events and death in patients with heart failure. Circ J 2011, 75:1661-1669.
46. Dunderdale K., Thompson D.R., Beer S.F., Furze G., Miles J.N. Development and validation of a patient-centered health-related quality-of-life measure: the chronic heart failure assessment tool. J Cardiovasc Nurs 2008, 23:364-370.
47. Shabetai R. Cardiomyopathy: how far have we come in 25 years, how far yet to go?. J Am Coll Cardiol 1983, 1:252-263.
48. Tate C.W., Robertson A.D., Zolty R., et al. Quality of life and prognosis in heart failure: results of the Beta-Blocker Evaluation of Survival Trial (BEST). J Card Fail 2007, 13:732-737.
49. Dracup K., Walden J.A., Stevenson L.W., Brecht M.L. Quality of life in patients with advanced heart failure. J Heart Lung Transplant 1992, 11:273-279.
50. Dunbar S.B., Jenkins L.S., Hawthorne M., et al. Factors associated with outcomes 3 months after implantable cardioverter defibrillator insertion. Heart Lung 1999, 28:303-315.
51. Stephen S.A. Fatigue in older adults with stable heart failure. Heart Lung 2008, 37:122-131.
52. Wiklund I., Lindvall K., Swedberg K., Zupkis R.V. Self-assessment of quality of life in severe heart failure: an instrument for clinical use. Scand J Psychol 1987, 28:220-225.
53. Wiklund I., Waagstein F., Swedberg K., Hjalmarsson A. Quality of life on treatment with metoprolol in dilated cardiomyopathy: results from the MDC trial. Metoprolol in Dilated Cardiomyopathy trial. Cardiovasc Drugs Ther 1996, 10:361-368.
54. O'Leary C.J., Jones P.W. The left ventricular dysfunction questionnaire (LVD-36): reliability, validity, and responsiveness. Heart 2000, 83:634-640.
55. Conti J.B., Sears S.F. Cardiac resynchronization therapy: can we make our heart failure patients smarter?. Trans Am Clin Climatol Assoc 2007, 118:153-164.
56. Zambroski C.H., Lennie T.A., Chung M.L., Heo S., Smoot T., Ziegler C. Use of the Memorial Symptom Assessment Scale-Heart Failure in heart failure patients. Circulation 2004, 110(Supplement III):17.
57. Portenoy R.K., Thaler H.T., Kornblith A.B., et al. The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer 1994, 30A:1326-1336.
58. Zambroski C.H., Moser D.K., Bhat G., Ziegler C. Impact of symptom prevalence and symptom burden on quality of life in patients with heart failure. Eur J Cardiovasc Nurs 2005, 4:198-206.
59. Aiken L.S., Butner J., Lockhart C.A., Volk-Craft B.E., Hamilton G., Williams F.G. Outcome evaluation of a randomized trial of the PhoenixCare intervention: program of case management and coordinated care for the seriously chronically ill. J Palliat Med 2006, 9:111-126.